StockNews.com Downgrades Puma Biotechnology (NASDAQ:PBYI) to Buy
Puma Biotechnology (NASDAQ:PBYI – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. Separately, HC Wainwright reiterated a “buy” rating and issued a $7.00 price target on shares of Puma Biotechnology in a research note on Friday, […]
Puma Biotechnology (NASDAQ:PBYI – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. Separately, HC Wainwright reiterated a “buy” rating and issued a $7.00 price target on shares of Puma Biotechnology in a research note on Friday, […]
